Showing posts with label Investment Tips. Show all posts
Showing posts with label Investment Tips. Show all posts

Top Stock Picks: Bank, NBFC & HFC Stocks To Buy Ahead of Q4FY22 Results



The brokerage firm HDFC Securities has given an eye on the banking space and has picked up Axis Bank for a target price of Rs 1,021, Bandhan Bank for a target price of Rs 406, City Union Bank for a target price of Rs 213, Federal Bank for a target price of Rs 126, ICICI Bank for a target price of Rs 1,001 as its top picks with a buy rating. Whereas, Cholamandalam Investment and Fin Co (CIFC) for a target price of Rs 774, CreditAccess Gr for a target price of Rs 994, and SBI Card with a target price of Rs 1,255 are the brokerage's top selections in the NBFC and HFC sector, with a buy rating ahead of Q4FY22E results.  



BanksRecommendationTarget Price in Rs
AU Small Finance BankREDUCE1,264
Axis BankBUY1,021
Bandhan BankBUY406
City Union BankBUY213
DCB BankADD131
Federal BankBUY126
ICICI BankBUY1,001
IndusInd BankREDUCE968
Kotak Mahindra BankREDUCE2,155
Karur Vysya BankADD58
RBL BankREDUCE160
Ujjivan Small Finance BankREDUCE21
NBFCs and HFCsRecommendationTarget Price in Rs
Bajaj FinanceREDUCE6,413
Cholamandalam Investment and Fin Co LtdBUY774
CreditAccess Grameen LtdBUY994
IndoStar Capital Finance LtdREDUCE229
LIC Housing Finance LimitedREDUCE409
Mahindra & Mahindra Financial Services LtdADD207
Repco Home Finance LtdADD290
SBI CARDBUY1,255
Shriram Transport Finance Co LtdADD1,641
Ujjivan Financial Services LtdADD201
Source: hdfcsec.com. Data as of 14 April 2022

Disclaimer- Investing in stocks is risky and investors need to be cautious. Neither Brokerage nor the author would be responsible for any losses incurred based on decisions made from the article. Please consult a professional advisor and avoid investing lumpsum amounts.
Share:

Top 5 Flexi Cap Fund Picks By Sharekhan To Start SIP In 2022


With the counter of the Russia-Ukraine crisis and a good rebound in economic indicators, the market is projected to see additional corrections in the near future. In the face of market uncertainty, experts feel that diversifying your portfolio can safeguard your returns from market downturns and that Flexi Cap funds are the best category to invest in.

When the market goes down, equity mutual funds struggle, but investors should not be worried about the risk. Alternatively, starting to invest in Flexi Cap funds, which invest in companies across the market capitalisation range, i.e. large-cap, mid-cap, and small-cap stocks, would be beneficial for moderate risk investors looking to build long-term wealth from equity while the market is volatile and betting on a single sector will not be favourable. As a consequence, we've compiled a list of the top 5 Flexi Cap funds chosen by brokerage firm Sharekhan in April 2022 to begin a Systematic Investment Plan (SIP) in order to combat the turbulence of the equity market.

Franklin India Flexi Cap Fund Direct Growth

Value Research has rated Franklin India Flexi Cap Fund Direct-Growth as a 3-star fund, with Rs 10,113.58 crores in assets under management (AUM) as of 31/03/2022 and a NAV of Rs 1,052.5630 as of 13/04/2022. The fund was established in 1994 and is ideally suited for long-term investors with a 5-year or longer financial goal. Franklin India Flexi Cap Fund Direct-Growth returns are 29.50 percent during the last year. It has had an average yearly return of 16.56 percent since its inception.

The fund has equity asset allocation across Financial, Technology, Consumer Staples, Energy, Automobile sectors and the fund's top 5 holdings are ICICI Bank Ltd., Infosys Ltd., HDFC Bank Ltd., Axis Bank Ltd., Bharti Airtel Ltd.. The fund has a 1.15 percent expense ratio, and SIPs can be started with as little as Rs 500.

PeriodAbsolute ReturnsAnnualised ReturnsCategory Avg
1 Week-1.00%--0.56%
1 Month6.52%-6.36%
3 Month-4.11%--4.44%
6 Month-2.21%--2.91%
YTD1.06%--0.36%
1 Year29.50%29.50%26.56%
2 Year120.08%48.35%42.26%
3 Year64.51%18.01%18.43%
5 Year94.17%14.18%14.62%
Since Inception314.90%16.56%15.32%
Source: moneycontrol.com. Data as of 13th April, 2022

UTI Flexi Cap Fund Direct Growth

Value Research has given UTI Flexi Cap Fund Direct-Growth a 5-star rating, and the fund was founded on May 18, 1992. As of 31/03/2022, UTI Flexi Cap Fund Direct-Growth has Rs 24,898.96 Crores in assets under management (AUM) and a NAV of Rs 247.9612 as of Apr 13, 2022. The 1-year returns of UTI Flexi Cap Fund Direct-Growth are 15.31% and it has returned an average of 12.88 percent every year since its inception.

The fund has its sector allocation across Financial, Technology, Healthcare, Services, Materials and the fund's top 5 holdings are Bajaj Finance Ltd., Larsen & Toubro Infotech Ltd., HDFC Bank Ltd., Infosys Ltd., ICICI Bank Ltd.. The fund has a 0.93 percent expense ratio, and SIPs can be started with as little as Rs 500 per month.

PeriodNAV (%)Nifty 500 Index(%)Nifty 50(%)
1 Year15.3122.2920.26
3 Years19.3516.7815.86
5 Years16.414.5515.14
Since Inception12.8811.920
Source: utimf.com. Data as of 31 Mar 2022

HDFC Flexi Cap Fund Direct Growth

The HDFC Flexi Cap Fund is a diversified equity fund that invests in big, mid, and small-cap stocks. Its benchmark is the NIFTY 500 Total Returns Index. This product is ideally suited for long-term investors with a financial objective of three years or more. The fund was founded on January 1, 1995, and as of 31/03/2022, HDFC Flexi Cap Direct Plan-Growth has Rs 27,496.23 crores in assets under management (AUM) and a NAV of Rs 1,120.08 crores as of 13th April 2022.

The previous one-year growth returns of the HDFC Flexi Cap Direct Plan were 34.87 percent. It has had an average yearly return of 15.37 percent since its inception. The fund's equity asset allocation is spread across the Financial, Energy, Capital Goods, Technology, and Materials sectors, with State Bank of India, ICICI Bank Ltd., Reliance Industries Ltd., Infosys Ltd., and National Thermal Power Corp. Ltd. as its top five holdings.

The fund has a 1.07 percent cost ratio, and SIPs can be started with as little as Rs 500 per month. Value Research has given the fund a two-star rating, indicating that investors should be cautious.

PeriodAbsolute ReturnsAnnualised ReturnsCategory Avg
1 Week-0.39%--0.56%
1 Month8.03%-6.36%
3 Month1.25%--4.44%
6 Month2.86%--2.91%
YTD7.59%--0.36%
1 Year34.87%34.87%26.56%
2 Year120.04%48.34%42.26%
3 Year57.21%16.25%18.43%
5 Year97.62%14.59%14.62%
Since Inception277.29%15.37%15.32%
Source: moneycontrol.com. Data as of 13th April, 2022

Canara Robeco Flexi Cap Fund Direct Growth

Canara Robeco Flexi Cap Fund Direct-Growth has been rated 5-star by Value Research and the scheme was founded on 16-Sep-2003. Canara Robeco Flexi Cap Fund Direct-Growth has Rs 7,256 crores in assets under management (AUM) and a NAV of Rs 222.08 as of 13-Apr-2022.

Canara Robeco Flexi Cap Fund Direct-Growth returns over the last year have been 20.82 percent, with an average annual return of 18.18 percent since inception. The fund has equity sector allocation across Financial, Technology, Healthcare, Energy, Automobile and the fund's top 5 holdings are Infosys Ltd., HDFC Bank Ltd., ICICI Bank Ltd., Reliance Industries Ltd., Bajaj Finance Ltd..

The fund has a 0.57 percent expense ratio, and SIPs can be started with as little as Rs 1000 each month.

PeriodCanara Robeco Flexi Cap Fund - GrowthScheme Benchmark (S&P BSE 500 TRI)Additional Benchmark (S&P BSE Sensex TRI)
CAGR since Inception18.18 %16.60 %16.76 %
1 Year20.82 %22.26 %19.50 %
3 Year17.96 %17.06 %16.06 %
5 Year16.20 %14.79 %15.94 %
Source: canararobeco.com. Data as of Mar 31 , 2022  

SBI Flexi Cap Fund Direct Growth

Before beginning to discuss the scheme's major takeaways, investors should be aware that SBI Flexi Cap Fund Direct-Growth is rated 3-star by Value Research. SBI Flexi Cap Fund Direct-Growth was established on September 29, 2005, and as of 31/03/2022, it has Rs 15,736.38 crores in assets under management (AUM) and a NAV of Rs 83.73 crores as of Apr 13, 2022.

The product has a 0.87 percent expense ratio, and SIPs can be started with as little as Rs 500. Financial, Services, Energy, Technology, and Consumer Discretionary are the fund's top sector allocations. HDFC Bank Ltd., ICICI Bank Ltd., HCL Technologies Ltd., Axis Bank Ltd., and ITC Ltd. are the fund's top five holdings. The 1-year returns for SBI Flexi Cap Fund Direct-Growth are 26.31 percent. It has had an average yearly return of 17.36% since its inception.

PeriodAbsolute ReturnsAnnualised ReturnsCategory Avg
1 Week-1.31%--0.56%
1 Month5.36%-6.36%
3 Month-2.71%--4.44%
6 Month-1.67%--2.91%
YTD1.87%--0.36%
1 Year26.31%26.31%26.56%
2 Year101.63%41.99%42.26%
3 Year63.32%17.73%18.43%
5 Year97.91%14.62%14.62%
Since Inception340.91%17.36%15.32%
Source: moneycontrol.com. Data as of 13th April, 2022
Disclaimer:- The views and investment tips expressed by author of IPOOnly, should not be construed as investment advice to buy or sell stocks, gold, currency, or other commodities. Investors should certainly not take any trading and investment decision based only on information discussed on IPOOnly We are not a qualified financial advisor and any information herein is not investment advice. It is informational in nature. All readers and investors should note that author of the articles, would not be responsible for any decision taken based on these articles. Please do consult a professional advisor. 
Share:

Sharekhan Recommends 5 Pharma Stocks To Buy For Upto 57% Upside

 



These are 5 pharma stocks that have been recommended by brokerage firm Sharekhan to buy for good returns.

Aurobindo Pharma (ARV)

Maintaining a Buy rating for Aurobindo Pharma (ARV), with a Target Price of Rs. 875, Sharekhan estimates an upside of 33%. However, Sharekhan revised earnings estimates for ARV down by around 5% for both FY22E and FY23E.

Cipla

Maintaining a Buy rating for Cipla, with a Target Price of Rs. 1,150, Sharekhan estimates an upside of 28%. the company reported a strong Q2FY22 report, and the brokerage firm is expecting healthy results for FY2022E and FY2023E.

Cadila Healthcare


Maintaining a Buy rating for Cadila Healthcare, with a Target Price of Rs. 720, Sharekhan estimates an upside of 57%. the company also reported a healthy report for the Q2FY22, and Sharekhan is estimating a similar growth in the upcoming days.

Ipca Laboratories


Maintaining a Buy rating for Ipca Laboratories, with a Target Price of Rs. 2,675, Sharekhan estimates an upside of 30%. However, the management is expecting near-term challenges for the company's API business, along with possibilities of a rise in raw material and logistics prices. Sharekhan has downgraded the company's estimates for FY22E to FY24E by 4%-7%.

Lupin

Maintaining a Buy rating for Lupin, with a Target Price of Rs. 1,210, Sharekhan estimates an upside of 35%. The Q2FY22 results of the company have fallen marginally due to escalating raw material prices. The brokerage firm has revised down the company's estimates by 8-10% for FY22E/FY23E.

Source - Goodreturns.in

Disclaimer-

Investing in stocks is risky and investors need to be cautious. Neither Brokerage nor the author would be responsible for any losses incurred based on decisions made from the article. Please consult a professional advisor and avoid investing lumpsum amounts.

Share:

Banking Stocks To Buy As Suggested By Motilal Oswal For Up To 30% Gains


Motilal Oswal has a buy call on 7 banking stocks in its latest India Strategy report. According to the report, among the banking stocks include private sector, public sector and small finance banks. "We estimate public sector banks to report improved operating performance, supported by modest business growth and a gradual reduction in provisions," the brokerage has said.

Equitas Holdings

Current market price- Rs 123
Target price - Rs 160

The brokerage sees a near 30% upside on the stock of Equitas Holdings and believes that net interest margins would remain stable at around 8%. The brokerage says that it remains watchful of asset quality in MSME book; focus to remain on CE and restructuring book, it has noted.

Federal Bank: Buy the stock for a price target of Rs 110

Current market price - Rs 84
Target price - Rs 110

Federal Bank is another stock where the brokerage sees a near 30% upside from the current levels. Motilal Oswal believes that the Business growth for Federal Bank would remain modest, while asset quality will remain a monitorable.

Indian Bank: Buy the stock with a price target of Rs 175

Current market price - Rs 140
Target price - Rs 175

The brokerage sees a near 25% upside on the stock of Indian Bank from the current levels. Motilal Oswal believes that the loan growth will witness an uptick and the margins for the bank would remain stable around 3.1%.

RBL Bank

Current market price - Rs 192
Target price - Rs 235

The brokerage sees an upside of nearly 23% on the stock of RBL Bank and has a buy call on the stock. Motilal Oswal Financial Services believes that asset quality of the bank will remain under pressure on exposure to MFI / Credit Cards. Among the monitorables according to the brokerage would be Growth in deposits and liquidity positioning.

Buy AU Small Finance Bank stock

Current market price - Rs 1226
Target price - Rs 1400

According to the brokerage margins for the bank are likely to witness an increase to 5.7%, while CoF and C/I ratio are other key monitorables. It also feels that business growth will witness a healthy pick-up.


Axis Bank: Buy the stock with a price target of Rs 925

Current market price - Rs 780 
Target price - Rs 925

According to Motilal Oswal, credit costs will remain elevated for Axis Bank, while slippage - a key monitorable to assess the impact on asset quality. The margins for the bank are expected to remain stable, while the brokerage expects business growth to pick-up.


Bank of Baroda

Current market price - Rs 84
Target price - Rs 100

The brokerage sees an upside of at least 19% on the stock of Bank of Baroda from the current market price of Rs 84. Elevated credit costs are likely to keep earnings under pressure, while slippages to our expected to be under pressure, feels Motilal Oswal.

Share:

Auto Ancillary Stocks To Buy As Suggested By Emkay Global


 Buy Apollo Tyre with upside potential of 37%

Emkay Global suggests buying the stock of Apollo Tyre for a target price of Rs. 305 per share, i.e. an upside of over 37 percent from the last traded price of Rs. 222.

The APMEA (20%) and Europe areas will drive revenue growth (3 percent ). Despite the greater size, EBITDA margins should fall due to delays in commodity inflation pass-through.


Exide Industries

Emkay Global suggests buying the stock of Exide Industries for a target price of Rs. 4,420 per share, i.e. an upside of over 17 percent from the last traded price of Rs.3771.

Replacement and industrial markets should drive revenue growth. Due to a favorable base, the company should outperform AMRJ in terms of sales growth. Despite the greater size, EBITDA margins should fall due to delays in commodity inflation pass-through.


Buy Motherson Sumi with upside potential of 34%

Motherson Sumi's stock is recommended by Emkay Global with a target price of Rs. 300 per share, representing a gain of almost 34% over the latest traded price of Rs.224.

Total revenues are likely to fall due to poor performance in the SMR PBV sector (-20 percent yoy). In comparison, the solo (22 percent) and PKC (42 percent) categories are predicted to increase at a good rate. Due to lower scale and delays in commodity inflation pass-through, the EBITDA margin may fall.


Buy Bharat Forge with upside potential of 27%

Emkay Global has set a target price of Rs. 920 per share for Bharat Forge's stock, reflecting a gain of over 27% over the current market price of Rs.722.

Domestic CVs (115 percent yoy), foreign CVs (189 percent), and overseas industrials should all see considerable growth (77 percent ). Despite a lag in commodity inflation pass-through, we estimate EBITDA margin expansion due to increased scale.

 

Buy Minda Industries with potential of 14%

Emkay Global has set a target price of Rs. 840per share for Minda Industries's stock, reflecting a gain of over 14% over the current market price of Rs734.

Growth in sectors such as Castings, Seating, Switches, and Others (sensors, etc.) will boost total revenue growth. Acoustics and lighting systems, on the other hand, are expected to decline. EBITDA margins may decline, owing to delays in commodity inflation pass-through and increasing personnel expenses

Share:

Three Stocks That Can Give Good Returns In Short Term, Says ICICI Securities

 


Buy Sudarshan Chemical, Says ICICI Securities

Sudarshan Chemical, which was founded in 1951, is a major participant in the Indian colour pigment sector, with a 35 percent market share, and is also one of the top four companies globally.


ICICI Securities believes that the revenue growth of specialty pigments is expected to be aided by upcoming capex. To improve the business's margin profile, a higher share of value-added business portfolio is required. Allocating additional FCF to organic and inorganic growth is anticipated to expand return ratios even more.

Current Market PriceRs 642
 Target Price Rs 795 
 Upside Potential 24%

Sudarshan Chemical: Upcoming capex offers strong visibility ahead

ICICI Securities has retained a Buy on the stock with a revised price target of Rs795. "The stock appreciated at 30% CAGR in last three years. We retain BUY rating on the back of better growth outlook from speciality pigments Target Price and Valuation: We value Sudarshan Chemical at 25x P/E FY23E EPS to arrive at a revised target price of Rs 795/share.

Apart from Sudarshan Chemical, we also appreciate Neogen Chemical in our chemical coverage. Future revenue growth for Neogen Chemical is projected to be driven by more bespoke synthesis opportunities," the brokerage has said.

Buy Motherson Sumi: ICICI Securities

Motherson Sumi (MSS) principally services the global PV industry with essential product lines such as wiring harnesses, vision systems (mirrors), and plastic body parts.

According to ICICI Securities, they expect a 12.6 percent net sales CAGR from FY21 to FY23E, backed by a healthy expected revival in global OEM client volumes and a strong orderbook. Minimal EV risk, with EV share of orderbook at 25% (FY21). Focus on higher content per vehicle to gain traction. Margins seen rising to 10.8 percent by FY23E, backed by higher capacity utilisation at greenfield plants and gene.

Current Market PriceRs 225
 Target Price  Rs 270
 Upside Potential 20%

Target price of Rs 270 on the stock

"MSS' stock price has grown at ~10% CAGR from ~Rs 145 levels in August 2016, widely outperforming the Nifty Auto index. We retain BUY rating on global PV premiumisation play, EV neutral products Target Price and Valuation: We value MSS at 30x P/E on FY23E basis for a revised target price of Rs 270 (earlier Rs 300).

Buy Trent, Says ICICI Securities

Trent is India's largest retailer, having 400+ outlets and a presence in a variety of consumer sectors. Trent is one of the fastest growing companies in our retail coverage universe, because to the inherent power of its brands (Westside, Zudio, Star, Zara) and expedited store openings.

ICICI Securities believes that for FY22-23E, we estimate 175 new stores between Westside and Zudio. Expect revenue recovery to pick up speed from H2FY22 onwards, with revenue and profits CAGRs of 17 percent and 36 percent in FY20-23E, respectively. The company wants to expand its sales at a CAGR of 25%+ in the long run.

Current Market PriceRs 947
Target PriceRs 1100
Upside Potential16%



DISCLAIMER

Investing in stocks is risky and investors need to be cautious. Neither Brokerage nor the author would be responsible for any losses incurred based on decisions made from the article. Please consult a professional advisor and avoid investing lumpsum amounts.
Share:

Four Stocks To Buy For Long Term



Dabur India 
Current market priceRs 603
Target priceRs 714
Upside18.00%

Broking firm, Motilal Oswal has said to buy the stock of Dabur India with an upside target of 18% on the stock. According to the broking firm, the management's confidence remains double-digit sales growth prospects for FY22, despite a challenging base for the Healthcare business in the remaining quarters. It also has a target of maintaining or growing FY22 EBITDA margin YoY, despite the ongoing rise in material costs, is encouraging.

"Dabur has delivered double-digit topline growth in two of the past three years, unlike most peers, and is likely to do so again in FY22.

New products now contribute 5-6% of sales. Earnings growth, after the ongoing investment in these initiatives, will be even stronger than topline growth after completion of the investment phase for the above mentioned initiatives (and a temporary reset on account of a step up in taxation levels to 22% in FY22 from 17.6% in FY21). We maintain our buy rating," the brokerage has said.


Castrol

Brokerage firm, Motilal Oswal also has a buy call on the stock of Castrol, with a 22% upside target from the current levels.

Current market priceRs 140
Target priceRs 170
Upside17.00%

According to the brokerage firm, the management guided that demand momentum has picked up since June'21 and is expected to continue (although a potential third wave may be a critical development).

"Castrol has always enjoyed its brand equity heritage, and we believe it would be able to secure its profitability with a better product mix, cost control, and the launch of advanced products with better realization. We value the stock at 20 timesJune'23E EPS to arrive at target price of Rs 170. Maintain Buy," the brokerage has said.


Punjab National Bank

Motilal Oswal has a neutral call on the stock of Punjab National Bank, but, sees an upside of 11% on the stock from current levels.

Current market priceRs 40.40
Target priceRs 45
Upside11.00%

Punjab National Bank reported a healthy performance, supported by a pick-up in net interest income, higher other income, and lower operational expenditure, even as provisions stood stable QoQ.

"Business growth remains muted, however margin witnessed a sequential uptick. The bank expects growth to pick up, led by RAM segments, while the Corporate book too would undergo a gradual recovery. Asset quality was largely stable, despite higher slippages, supported by recoveries and upgrades. SMA 1 and 2 book stands elevated at 3.9% of loans, while restructured book, at 2.02% of loans (expect a further restructuring of Rs 15-20 billion), keeps us watchful over the near term. We estimate a RoA/RoE of 0.6%/8.8% by FY23E. We resume coverage with a Neutral rating and a target of Rs 45 (0.6 times FY23E ABV)," the brokerage has said.


Bharti Airtel

The brokerage is also bullish on the stock of Bharti Airtel. The brokerage says that Africa will remain the underdog and the business saw strong 9% EBITDA growth QoQ, backed by all-round growth in Data and Airtel Money consistently over the last few quarters. It generates Rs 400-500m FCF and remains a business that exhibits low leverage and healthy growth. Motilal Oswal says that despite robust data traffic volumes of 108b GB (18.9 GB/user), data traffic/subscribers are 50% that of RJio.

According to Motilal Oswal the EBITDA has been 30% higher for the last year, highlighting that the healthy subs/ARPU equation is showing gains. All this without any tariff hikes, the brokerage has said. It has a buy on the stock, but has not indicated any target prices for the same.



DISCLAIMER

Investing in stocks is risky and investors need to be cautious. Neither Brokerage nor the author would be responsible for any losses incurred based on decisions made from the article. Please consult a professional advisor and avoid investing lumpsum amounts.
Share:

Three Smallcap Stocks to Include in Your Portfolio


 In the smallcap universe, we have picked up three scrips that hold promise for the future.


Rossari Biotech Ltd

Rossari Biotech is a specialty chemical and textile chemical manufacturing company. It is the largest textile specialty chemical manufacturer of India. They operate in three main segments: Home and personal care, Textile chemicals, Animal Health, and Nutrition products. They have over 2,000 plus products under these three categories. The key strength of the company is that they have a very diversified product portfolio. With a good research facility and pan India distribution network, they can increase their customer base. The current situation of the pandemic has made people realize the importance of hygiene. Thus the demand for disinfectants, antibacterial and antimicrobial textile material has increased significantly. The need for these products will expedite its revenue growth.

From the last five years, the company has reported a steady rise in revenue and net profits. Its net profit was Rs 79.10 crore in FY2021, up 403% compared to Rs 15.72 crore in FY2017. In FY2021, Rossari reported a consolidated total income of Rs 700.62 crore, up 16% from Rs 603.7 crore in FY2020. Its profit after tax was up 20.7% year-on-year during the same period. The stock gained 69.8% in a year, 40.3% in six months, and 1.8% in a month. Currently, it is trading at an 8.4% discount to its 52-week high.

Route Mobile Ltd 

Route Mobile is India's one of the leading cloud computing services providers. They offer services to enterprises, OTT players, and mobile operators. The company also offers text messaging, voice calling, firewall, email services to their clients worldwide. The recent acquisition of the email communication platform of Sarv Webs will help the company provide a complete customized email interaction platform to its clients. The growing use of OTT platform, OTP services by various sectors should boost its revenue in the future. The three years revenue CAGR growth was 40.8% and 39.9% for net profit. Revenue was Rs 1,422.2 crore in FY2021, up 46.9% compared to Rs 968.1 crore in FY2020. Its net profit of Rs 133.3 crore more than doubled during the same period. The scrip returned 225.1% in a year, 66.8% in six months, and a staggering 24.8% in a month, indicating continued momentum in the stock.

Mazagon Dock Shipbuilders Ltd

Mazagon Dock is a government company operating under the Ministry of Defense. The company is known as 'hip builders of the nation'. The company's shipbuilding division offers building and repairs of naval ships, whereas the submarine and heavy engineering divisions include building, repairing, and refitting diesel-electric submarines. Overall the outlook for the defense sector is positive. The government has recently banned importing 101 defense items reflecting the Government'sGovernment's focus on promoting and creating opportunities for Indian companies. It should drive the top-line of Mazagaon shipbuilders in the near to medium term.

The company's net profit in Q4FY2021 was Rs 230.54 crore, up a whopping 455% compared to Rs 41.55 crore in the corresponding period of fiscal 2020. The scrip jumped 51.8% in a year, 27.9% in six months, and 3.6% in a month, indicating a continued momentum.
Share:
X

Get Updates on Facebook

Like our Page. Become a FAN!

Contact Us

Recent Posts